摘要
随着肝脏外科技术的发展、新型免疫抑制剂的应用以及肝移植术后受者管理的进步,肝移植的预后得到极大改善。然而,供肝资源短缺制约了肝移植的进一步发展。近年来,心脏死亡器官捐献(DCD)供肝在原位肝移植中的应用,有效扩大了供肝数量。但是DCD供肝作为扩大选择标准的供肝来源,如何有效地评估其质量以保证移植后生存率和受者安全尚未达成共识。本文将这一领域的最新进展作一综述。
Improvements in surgical techniques, immunosuppression, and post-transplantation patient care have led to the optimization of liver transplantation outcomes. However, the scarcity of donor liver has restricted further development of liver transplantation. In recent years, the use of donation after cardiac death （DCD） liver effectively expanded the donor pool. However, how to effectively assess the quality of DCD liver in order to ensure liver transplantation survival and transplant recipient safety is no consensus. Therefore, the present work reviewed the latest developments in this field.
出处
《中华移植杂志（电子版）》
CAS
2015年第1期38-41,共4页
Chinese Journal of Transplantation(Electronic Edition)
